Cancer-associated Cachexia study: Visugromab
Official title Visugromab in Cachexia International Trial
ClinicalTrials.gov ID: NCT07112196
What this study is testing
What is Visugromab?
an investigational intravenous drug being studied for cancer-associated cachexia
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to find out if visugromab helps people put weight back on, improves their appetite, and allows them to move more easily. It also looks for any medical problems that might happen while taking the drug.
- Who it's for
- The study is looking for people with certain types of cancer, such as lung or bowel cancer, who are experiencing unintended weight loss.
- What's involved
- Participants will receive either the new drug or a look-alike substance with no medicine through a drip into a vein. They will also have regular checkups and tests to monitor their health.
- Time commitment
- Participants need to visit the hospital or clinic once every 4 weeks to get their treatment and tests.
- Phase 3: a large, late-stage study
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Weight loss
- Advanced cancer
You likely can't join if
- Participation in another treatment clinical trial, receipt of any investigational therapy or use of any investigational device within 4 weeks prior...
The study team makes the final eligibility decision.
Where it is enrolling
- Norwich, Connecticut, United States
- Clermont, Florida, United States
- Orange City, Florida, United States
- Stuart, Florida, United States
- Weston, Florida, United States
- Augusta, Georgia, United States
- East Brunswick, New Jersey, United States
- Avon, Ohio, United States
- Cleveland, Ohio, United States
- Fairview, Ohio, United States
- Mayfield Heights, Ohio, United States
- Haskovo, Bulgaria
- Plovdiv, Bulgaria
- Sofia, Bulgaria
- Vratsa, Bulgaria
- Hořovice, Czechia
- Hradec Králové, Czechia
- Olomouc, Czechia
- Prague, Czechia
- Brest, France
+ 50 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Norwich, Connecticut, United States; Clermont, Florida, United States; Orange City, Florida, United States; Stuart, Florida, United States; Weston, Florida, United States; Augusta, Georgia, United States and 64 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.